The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
It's estimated that each year in the United States, more than 400,000 babies are born to mothers who are depressed. Without any treatment, postpartum depression can last for months or even years, according to the National Institute of Mental Health.In February, drugmakers Biogen and Sage Therapeutics, Inc.
, a neuroactive steroid that is a metabolite of the hormone progesterone. Levels of allopregnanolone can rise dramatically during pregnancy and then abruptly drop after childbirth, potentially contributing to postpartum depression. Postpartum depression "is often underdiagnosed and undertreated. With the FDA's decision today, we may be able to reverse this and help many more women in need," Deligiannidis said., found that among 151 women with severe postpartum depression, the patients taking daily zuranolone at 30 milligrams for two weeks experienced greater reductions in their depressive symptoms compared with those taking a placebo.
"It will be an important tool in treating postpartum depression. Rapidly acting antidepressant therapies are needed and this would be the first oral drug formulation of a rapidly acting antidepressant. That is a very big deal for moving the bar forward to improve treatment options for women with postpartum depression," Meltzer-Brody said in the email.
"It needs to be clear that it originally was established as having efficacy mainly with people who had severe depression," she said. "Also, there are significant health disparities in the rates of postpartum depression, much higher rates for those living in poverty and minoritized populations."
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Weiterlesen »
The first pill to treat postpartum depression has been approved by US health officialsThe Food and Drug Administration on Friday granted approval of the drug, Zurzuvae for adults experiencing severe depression related to childbirth or pregnancy.
Weiterlesen »
The biggest names in food are just regular people on TikTokThe millions of followers flocking to folks cooking on newer social media platforms shows a deep interest in cooking, finding inspiration for daily meals, and even in figuring out where to go eat. (via voxdotcom)
Weiterlesen »
FDA approves first pill to treat postpartum depressionZurzuvae, a pill meant to treat severe depression after giving birth, is the first of its kind to be approved by the U.S. Food and Drug Administration.
Weiterlesen »
Anti-abortion group challenges abortion pill with Clean Water ActAn anti-abortion student organization is petitioning the Food and Drug Administration to rescind its approval of the abortion pill mifepristone, calling for an assessment of water contamination.
Weiterlesen »
FDA approves first postpartum depression pill in the USThe US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Weiterlesen »